ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
41.02
0.61%
US Tech 100
21,170.00
1.66%
S&P 500
6,084.19
0.82%
US Dollar vs CAD
1.41625
-0.11%
Bitcoin
101,095.95
4.57%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Cytek Biosciences Inc (CTKB) Share Price

Cytek Biosciences Inc

Cytek Biosciences Inc (CTKB)

NASDAQ
6.565
-0.165
(-2.45%)
At close: December 11 3:00PM
Delayed by 15 minutes
6.56
-0.005
( -0.08% )
After Hours: 3:04PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
6.56
Bid
6.43
Ask
6.87
Volume
418,142
6.455 Day's Range 6.77
4.66 52 Week Range 9.87
Market Cap
844.998M
Previous Close
6.73
Open
6.76
Last Trade
561
@
6.56
(priorref)
Last Trade Time
15:01:56
Financial Volume
US$ 2,772,345
VWAP
6.6302
Average Volume (3m)
686,630
Shares Outstanding
128,810,614
Dividend Yield
-
PE Ratio
-69.57
Earnings Per Share (EPS)
-0.09
Revenue
193.02M
Net Profit
-12.15M

About Cytek Biosciences Inc

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-co... Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Website
www.cytekbio.com
Headquarters
Dover, Delaware, USA
Founded
-
Cytek Biosciences Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker CTKB. The last closing price for Cytek Biosciences was US$6.73. Over the last year, Cytek Biosciences shares have traded in a share price range of US$ 4.66 to US$ 9.87.

Cytek Biosciences currently has 128,810,614 shares outstanding. The market capitalization of Cytek Biosciences is US$866.90 million. Cytek Biosciences has a price to earnings ratio (PE ratio) of -69.57.

Ask ADVFN Intelligence (AI)

CTKB Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

November 20 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 20 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 20 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 20 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 20 2024
Edgar (US Regulatory)

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

FREMONT, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...

November 20 2024
GlobeNewswire Inc.

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

FREMONT, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) announced today that it has been named “Overall BioTech Company of the Year” in the fourth annual...

November 19 2024
GlobeNewswire Inc.

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

FREMONT, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) has introduced an Enhanced Small Particle (ESP™) Detection Option for its Cytek Aurora™ CS system. This...

November 07 2024
GlobeNewswire Inc.

Form 8-K - Current report

November 05 2024
Edgar (US Regulatory)

Cytek Biosciences Reports Third Quarter 2024 Financial Results

FREMONT, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...

November 05 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.12-1.796407185636.686.896.4156068826.67295989CS
4-0.59-8.251748251757.157.155.686036776.50178743CS
121.2122.61682242995.357.634.666866306.00026888CS
260.6410.81081081085.927.634.666421255.85969951CS
52-1.1-14.36031331597.669.874.666833126.68172059CS
156-11.99-64.636118598418.5519.2453.88134219.27915212CS
260-13.54-67.363184079620.128.73.87517229.86076172CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CTHRCharles and Colvard Ltd
US$ 2.62
(66.87%)
710.18k
DBVTDBV Technologies SA
US$ 4.71
(43.16%)
853.44k
PALIPalisade Bio Inc
US$ 1.90
(35.71%)
2.15k
BSFCBlue Star Foods Corporation
US$ 0.40
(26.18%)
796.04k
SGRPSpar Group Inc
US$ 2.14
(15.05%)
843.71k
BCTXBriaCell Therapeutics Corporation
US$ 0.855
(-21.56%)
353.16k
GELSGelteq Ltd
US$ 4.32
(-12.37%)
1.42k
YJYunji Inc
US$ 1.92
(-8.57%)
1.41k
NIVFNewGenIvf Group Ltd
US$ 0.3331
(-7.47%)
316k
BKYIBIO key International Inc
US$ 1.00
(-6.54%)
1k
LAESSEALSQ Corporation
US$ 1.14
(-0.05%)
2.11M
ESGEiShares Inc iShares ESG Aware MSCI EM ETF
US$ 35.1115
(-0.39%)
2.06M
WBDWarner Brothers Discovery Inc
US$ 10.82
(-0.05%)
1.61M
QQQInvesco QQQ Trust Series 1
US$ 529.92
(-0.00%)
1.25M
JZXNJiuzi Holdings Inc
US$ 2.03
(13.28%)
1.13M

Discussion

View Full Feed
Gmenfan Gmenfan 3 minutes ago
BOOM: Pete Hegseth Cuts Lefty Rag ProPublica Off at the Knees Before They Publish West Point Hit Piece

https://twitchy.com/amy-curtis/2024/12/11/hegseth-propublica-n2405009
meixatech meixatech 4 minutes ago
"... team of researchers led by Dr. Dennis Lal at Cleveland Clinic published an updated incidence for rate for STXBP1 of 3.3 to 3.8 children per 100,000 births.[1] This is 1 in 26,000 to 1 in 30,000 births or over 10 STX’ers born a day.

Based on the numbers in our community Facebook g
RSPI
gitreal gitreal 4 minutes ago
Do clarify because not everyone can see sarcasm 🤣

Doesn't seem like sarcasm because it is exactly like what the company would write in a PR, or one of its promoters would say on a social media post.
BMXI
WhenLambo WhenLambo 4 minutes ago
could that be a way for a few to hoard all of the gains from finally getting success and leaving all the shareholders here out in the cold?
TPTW
NEnorth NEnorth 4 minutes ago
That was me selling 100 shares That made it tank ...
CBRF
Nelson2 Nelson2 4 minutes ago
Hey pal. How about jumping on China first. Building coal plants all around the world
Coal usage peaked in 2023
Stop picking up pennies when there are dollar bills everywhere

GLTA
MSTR
allenc allenc 4 minutes ago
Actually AS is 5B. 4B more shares to dilute and this clown will dilute this to oblivion JMO
EMED
tmcfo tmcfo 5 minutes ago
Who knows if mvnt has been or is currently a customer. Maybe company utilized them when they were developing the website. In any case, it hasn't helped in growing revenues..
MVNT
just Scottie just Scottie 5 minutes ago
Sounds dismal
FUNR
LOVELWLG LOVELWLG 5 minutes ago
I guess someone is constructed new copy and paste posts. Lebbys old ones have little to no value now. Totally misleading to say the least. 🤣🤣🤣🤣
No ramp up
No customer acceptance
No Teir 1 signing or any signings in 18 months.
No Dr Lebby.
LWLG
TheKRA TheKRA 5 minutes ago
Surprisingly, yes. With lower than average volume too.
NKLA
lighter than AIR lighter than AIR 6 minutes ago
23k in buys…less than four hundred in sells….MM bid whack to end the day is why we’re down.
CBRF
glenn1919 glenn1919 6 minutes ago
bsgm....pali......................................................A/H
JMCK6193 JMCK6193 6 minutes ago
Hopefully insiders 
NXPL
skeptic7 skeptic7 6 minutes ago
Huh?
FNMA
SorcererDiviner18 SorcererDiviner18 6 minutes ago
Oh, excellent! Disclaimers + the actual patent context provide a comprehensive overview.

This is just one of the patents, as I did not want to post all of them in one text.

I don't get paid to provide a service, so you will have to accept the editing that I provided (i
API
Deano361 Deano361 6 minutes ago
I believe them. There is no revenue until recently and it's minimal and just this past month. The investors (me being one) who put money in , are just keeping the lights on. To just stay compliant , pay attorneys, tax, otc fees etc.. is easily $100k per year. He has not received that much in 202
FUNR
Filterthenoise Filterthenoise 6 minutes ago
We all know what you are. Refund your boss and find a new gig🎅
RNVA
glenn1919 glenn1919 6 minutes ago
pali............................https://stockcharts.com/h-sc/ui?s=pali&p=W&b=5&g=0&id=p86431144783
PALI
Phaedrus77 Phaedrus77 7 minutes ago
I don't know why it was extended so many times, that's a good question. UDF put a poison pill in place, so NXDT was incapable of buying anything that was tendered even if they wanted to

We can go back and forth forever on this.

UDF management lied about its inability t
Biotechotcguy Biotechotcguy 7 minutes ago
Nice volume today. 
DROR
pzottkpz pzottkpz 7 minutes ago
They’re doing their best to get this thing to a blow off top if anyone else is really buying the FOMO?
In line numbers should have been …

🪟👗 before ⛷️

⏱️

💲SPXS
SPXS
Nelson2 Nelson2 7 minutes ago
Same ole diatribe

GLTA
CLNV
FROZENFLAME FROZENFLAME 7 minutes ago
$4.73 nice close, so far so good !
JTAI

Your Recent History

NASDAQ
CTKB
Cytek Biosciences
BOV
REGN34M
Regeneron Pharmaceuticals
BOV
NMRH34M
Nomura
BOV
N1VO34M
Novo Nordisk
BIT
P1QUO6
BNP Paribas Issuance
BIT
P12WZ9
BNP PARIBAS ISSUANCE
BIT
UC7F5C
Unicredit Bank
BIT
UC7KFZ
Unicredit Bank
BIT
F12519
Vontobel Financial Produ...
BOV
LJQQ3Q
Lojas Quero-Quero ON
BOV
IMAT
Basic Materials
BOV
CASN3
CASAN ON
BOV
CGEE4F
Companhia Estadual De Ge... PN
BOV
VALE-DEB82B0
VALE
BIT
P19732
BNP Paribas Issuance
BIT
P1EHR2
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved